Pacer Advisors, Inc. Abbott Laboratories Transaction History

Pacer Advisors, Inc.

$39 Billion
Q2 2024

A detailed history of Pacer Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Pacer Advisors, Inc. holds 148,313 shares of ABT stock, worth $16.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

148,313

Previous 155,865 4.85%

Holding current value

$16.7 Million

Previous $17.7 Million 13.01%

% of portfolio

0.04%

Previous 0.05%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $760,712 - $849,146	-7,552 Reduced 4.85%	148,313 $15.4 Million
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $1.16 Million - $1.28 Million	10,620 Added 7.31%	155,865 $17.7 Million
Q4 2023 Jan 16, 2024	BUY	$90.19 - $110.4 $2.64 Million - $3.23 Million	29,249 Added 25.22%	145,245 $16 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $218,954 - $262,709	-2,292 Reduced 1.94%	115,996 $11.2 Million
Q2 2023 Jul 12, 2023	BUY	$100.78 - $112.29 $839,396 - $935,263	8,329 Added 7.57%	118,288 $12.9 Million
Q1 2023 May 02, 2023	BUY	$96.86 - $114.01 $526,918 - $620,214	5,440 Added 5.2%	109,959 $11.1 Million
Q4 2022 Feb 06, 2023	BUY	$95.06 - $111.52 $8.82 Million - $10.3 Million	92,808 Added 792.49%	104,519 $11.5 Million
Q3 2022 Oct 18, 2022	BUY	$96.76 - $112.03 $54,669 - $63,296	565 Added 5.07%	11,711 $1.13 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $8.43 Million - $10.2 Million	-82,630 Reduced 88.11%	11,146 $1.21 Million
Q1 2022 Apr 05, 2022	SELL	$114.02 - $139.04 $154,155 - $187,982	-1,352 Reduced 1.42%	93,776 $11.1 Million
Q4 2021 Feb 03, 2022	SELL	$115.53 - $141.46 $1.88 Million - $2.3 Million	-16,254 Reduced 14.59%	95,128 $13.4 Million
Q3 2021 Oct 15, 2021	SELL	$116.66 - $129.06 $323,848 - $358,270	-2,776 Reduced 2.43%	111,382 $13.2 Million
Q2 2021 Jul 21, 2021	BUY	$105.79 - $124.53 $1.51 Million - $1.78 Million	14,289 Added 14.31%	114,158 $13.2 Million
Q1 2021 Apr 05, 2021	SELL	$108.84 - $128.23 $732,166 - $862,603	-6,727 Reduced 6.31%	99,869 $12 Million
Q4 2020 Jan 20, 2021	SELL	$105.0 - $114.42 $2.87 Million - $3.12 Million	-27,286 Reduced 20.38%	106,596 $11.7 Million
Q3 2020 Oct 19, 2020	SELL	$91.64 - $111.29 $1.98 Million - $2.4 Million	-21,566 Reduced 13.87%	133,882 $14.6 Million
Q2 2020 Jul 29, 2020	BUY	$76.57 - $98.0 $11.9 Million - $15.2 Million	155,311 Added 113365.69%	155,448 $14.2 Million
Q1 2020 Apr 23, 2020	SELL	$62.82 - $91.86 $12.7 Million - $18.6 Million	-202,915 Reduced 99.93%	137 $13,000
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $879,076 - $978,617	11,197 Added 5.84%	203,052 $17.6 Million
Q3 2019 Oct 10, 2019	BUY	$81.84 - $88.74 $1.87 Million - $2.03 Million	22,895 Added 13.55%	191,855 $16.1 Million
Q2 2019 Aug 12, 2019	BUY	$72.88 - $85.0 $878,349 - $1.02 Million	12,052 Added 7.68%	168,960 $14.2 Million
Q1 2019 Apr 10, 2019	BUY	$66.22 - $80.06 $10.4 Million - $12.5 Million	156,602 Added 51177.12%	156,908 $12.5 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $6.1 Million - $6.91 Million	-93,022 Reduced 99.67%	306 $22,000
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $707,950 - $854,057	11,642 Added 14.25%	93,328 $6.85 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $864,010 - $953,608	15,008 Added 22.51%	81,686 $4.98 Million
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $420,111 - $474,986	7,466 Added 12.61%	66,678 $4 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $786,626 - $842,165	14,654 Added 32.89%	59,212 $3.38 Million
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $2.14 Million - $2.39 Million	44,558	44,558 $2.38 Million

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Abbott Laboratories Transaction History